Expression levels of NFAT2 and Lck show correlation with clinical outcome in CLL patients

被引：0
|
作者：
Heitmann, J. S. [1 ]
Fuchs, A. R. [1 ]
Mrklin, M. [2 ,3 ]
Kopp, H. -G. [1 ]
Quintanilla-Fend, L. [4 ]
Kanz, L. [1 ]
Rao, A. [5 ]
Wirths, S. [1 ]
Mueller, M. R. [1 ]
机构：
[1] Univ Klinikum Tubingen, Med Klin & Poliklin 2, Abt Hamatol Onkol Immunl Pulmol & Rheumatol, Tubingen, Germany
[2] German Canc Consortium DKTK, Tubingen, Germany
[3] Partnerstandort Tubingen, German Canc Res Ctr DKFZ, Tubingen, Germany
[4] Univ Klinikum Tubingen, Abt Pathol, Tubingen, Germany
[5] La Jolla Inst Allergy & Immunol, San Diego, CA USA
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2017年 / 40卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P526
引用
收藏
页码：140 / +
页数：2
相关论文
共 50 条
  • [1] Lck is a direct target gene of NFAT2 in CLL
    Fuchs, A. R.
    Maerklin, M.
    Heitmann, J. S.
    Truckenmueller, F. M.
    Saur, S. J.
    Ganser, M.
    Bugl, S.
    Kopp, H. -G.
    Kanz, L.
    Rao, A.
    Wirths, S.
    Mueller, M. R.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 26 - 26
  • [2] NFAT2 Regulates Anergy Induction in CLL through Lck
    Maerklin, Melanie
    Heitmann, Jonas S.
    Poljak, Alexandra
    Bugl, Stefanie
    Kopp, Hans-Georg
    Haap, Michael
    Kanz, Lothar
    Rao, Anjana
    Wirths, Stefan
    Mueller, Martin R.
    BLOOD, 2014, 124 (21)
  • [3] NFAT2 regulates anergy induction in CLL through Lck
    Maerklin, M.
    Heitmann, J.
    Ganser, M.
    Bugl, S.
    Kopp, H. -G.
    Kanz, L.
    Rao, A.
    Wirths, S.
    Mueller, M. R.
    Oncology Research and Treatment, 2015, 38 : 200 - 200
  • [4] NFAT2 to regulate anergy induction in CLL through Lck
    Maerklin, Melanie
    Heitmann, Jonas S.
    Truckenmueller, Felicia
    Ganser, Manuela
    Kopp, Hans-Georg
    Wirths, Stefan
    Kanz, Lothar
    Rao, Anjana
    Mueller, Martin Rudolf
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [5] Nfat2 regulates anergy induction in CLL through Lck
    Maerklin, Melanie
    Heitmann, Jonas
    Ganser, Manuela
    Bugl, Stefanie
    Kopp, Hans-Georg
    Kanz, Lothar
    Rao, Anjana
    Wirths, Stefan
    Mueller, Martin R.
    LEUKEMIA & LYMPHOMA, 2015, 56 : 73 - 74
  • [6] Transcriptional mistargeting of NFAT2 in CLL
    Maerklin, M.
    Heitmann, J. S.
    Poljak, A.
    Ganser, M.
    Evouna, C.
    Stickel, J.
    Kopp, H. -G
    Kanz, L.
    Rao, A.
    Wirths, S.
    Mueller, M. R.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 221 - 221
  • [7] Overexpression and aberrant nuclear translocation of NFAT2 in CLL
    Heitmann, J. S.
    Maerkin, M.
    Worbs, D.
    Poljak, A.
    Stickel, J.
    Kanz, L.
    Wirths, S.
    Kopp, H-G
    Mueller, M. R.
    ONKOLOGIE, 2013, 36 : 222 - 222
  • [8] NFAT2 is a critical regulator of anergy induction in CLL
    Maerklin, M.
    Heitmann, J. S.
    Poljak, A.
    Ganser, M.
    Evouna, C.
    Kopp, H. -G
    Kanz, L.
    Rao, A.
    Wirths, S.
    Mueller, M. R.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 236 - 236
  • [9] Genetic loss of NFAT2 leads to CLL transformation
    Fuchs, A. R.
    Maerklin, M.
    Heitmann, J. S.
    Truckenmueller, F. M.
    Sour, S. J.
    Ganser, M.
    Bugl, S.
    Kopp, H. -G
    Kanz, L.
    Rao, A.
    Wirths, S.
    Mueller, M. R.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 11 - 12
  • [10] NFAT2 Is a Critical Regulator Of Anergy Induction In CLL
    Maerklin, Melanie
    Heitmann, Jonas S.
    Worbs, David
    Poljak, Alexandra
    Evouna, Claude
    Kopp, Hans-Georg
    Kanz, Lothar
    Rao, Anjana
    Wirths, Stefan
    Mueller, Martin R.
    BLOOD, 2013, 122 (21)
12345